New therapeutic targets in giant-cell arteritis. Considerations based on the current pathogenic model and the availability of new therapeutic agents

Clin Exp Rheumatol. 2008 May-Jun;26(3 Suppl 49):S141-50.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Drug Design*
  • Giant Cell Arteritis / drug therapy*
  • Giant Cell Arteritis / physiopathology*
  • Humans
  • Polymyalgia Rheumatica / drug therapy
  • Polymyalgia Rheumatica / physiopathology
  • Tumor Necrosis Factor-alpha / immunology


  • Tumor Necrosis Factor-alpha